癌抗原19-9（CA 19-9）檢測試劑盒（酶聯(lián)免疫法）產(chǎn)品說明:

【產(chǎn)品名稱】

通用名稱：癌抗原19-9（CA 19-9）檢測試劑盒（酶聯(lián)免疫法）

英文名稱：CA 19-9 ELISA

【預期用途】

CA19-9 ELISA試劑盒用于定量測定人血清或血漿中的癌抗原CA19-9濃度。僅供科研使用，不用于體外診斷。

【包裝規(guī)格】

96人份/盒

【背景知識】

一組粘蛋白型糖蛋白唾液酰劉易斯抗原（SLA），如CA19-9和CA19-5，已被公認為胃腸道癌的循環(huán)癌相關抗原。CA19-9是最重要和最基本的碳水化合物腫瘤標記物。CA19-9在組織中的免疫組織學分布與定量測定CA19-9濃度高于正常或炎癥組織的結果一致。最近的報道表明，胰腺癌、結直腸癌、胃癌和肝癌等各種胃腸道惡性腫瘤患者的血清CA19-9水平經(jīng)常升高。與CEA一起，CA19-9升高提示炎癥性膽囊疾病中的膽囊腫瘤。這種腫瘤相關抗原在某些非惡性疾病中也可能升高。研究表明，血清CA19-9值可用于監(jiān)測上述診斷為惡性腫瘤的受試者。LFTHA已經(jīng)表明，治療后血清CA19-9值持續(xù)升高可能預示著隱性轉移和/或殘留疾病。持續(xù)升高的血清CA19-9值可能與進行性惡性疾病和不良治療反應有關。CA19-9值下降可能表明預后良好，治療反應良好。

【產(chǎn)品相關】

樣本量：25 μl

儲存溫度：2-8 °C

參考文獻：

1. Glenn, J., Steinberg, W.M., Kurtzman, S.H., et at. evaluation of the utility of a radioimmunoassay for serum CA 19-9 level in patients before and after treatment of carcinoma of the pancreas. J. Clin. Oncol. 1988; 6:462-8.

2. Hayakawa, T., Kondo, T., Shibata, T. et al. Sensitive serum markers for detecting pancreatic cancer. Cancer 1988; 61:1827-31.

3. Koprowski, H., Herly, M., Steplewski, Z., et al. Specific antigen in serum of patients with colon carcinoma. Science 1981; 212:53-5

4. Malesci, A., Tommasini, M.A., Bonato, C. et al. Determination of CA19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis. Gastroenteroglogy 1987; 92:60-

5. Safi, F, Roscher, R., Bittner, R., et al. High sensitivity and specificity of CA 19-9 for pancreatic carcinoma in comparison to chronic pancreatitis. Serological and immunohistochemical findings. Pancreas 1987; 2:398-403.

6. Steinberg, W. The clinical utility of CA 19-9 tumor associated antigen. American J. of Gastroenterology 1990; 85:350-355.

7. Steinberg, W.M., Gelfand, R., Anderson, K.K., et al. Comparison of the sensitivity and specificity of the CA 19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas. Gastroenterology 1986; 90:343-9.

8. Takasaki, H., Uchida, E., Tempero, M.A., et al. Correlative study on expression of CA 19-9 and DU-Pan-2 in tumor tissue and in serum of pancreatic cancer patients. Cancer Res. 1988; 48:1435-8.

9. Tatsuta, M., Yamamura, H., Iishi H., et al. Values of CA19-9 in the serum, pure pancreatic juice and aspirated pancreatic material in the diagnosis of malignant pancreatic tumor. Cancer 1985; 56:2669-73.

10. Wang, T.H. Lin, J.W., Chen, D.S., et al. Noninvasive diagnosis of advanced panceatic cancer by real-time ultrasonography, carcinoembryonic antigen, and carbohydrate antigen 19-9. Pancreas 1986; 1:219-23.

11. Strom BL, Maislin G, West SL, et al. Serum CEA and CA19-9: potential future diagnostic or screening tests for gallbladder cancer? Int. J. Cancer 1990; 45:821.